These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8557016)

  • 1. The influence of hypothermia (surface cooling) on the time-course of action and on the pharmacokinetics of rocuronium in humans.
    Beaufort AM; Wierda JM; Belopavlovic M; Nederveen PJ; Kleef UW; Agoston S
    Eur J Anaesthesiol Suppl; 1995 Sep; 11():95-106. PubMed ID: 8557016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypothermic cardiopulmonary bypass influences the concentration-response relationship and the biodisposition of rocuronium.
    Smeulers NJ; Wierda JM; van den Broek L; Gallandat Huet RC; Hennis PJ
    Eur J Anaesthesiol Suppl; 1995 Sep; 11():91-4. PubMed ID: 8557015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of hypothermic cardiopulmonary bypass on the pharmacodynamics and pharmacokinetics of rocuronium.
    Smeulers NJ; Wierda JM; van den Broek L; Gallandat Huet RC; Hennis PJ
    J Cardiothorac Vasc Anesth; 1995 Dec; 9(6):700-5. PubMed ID: 8664462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamics and pharmacokinetics of rocuronium following continuous infusion in patients during intravenous anaesthesia.
    Sparr HJ; Khuenl-Brady KS; Eriksson LI
    Eur J Anaesthesiol Suppl; 1994; 9():63-5. PubMed ID: 7925211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of rocuronium bromide in patients with and without renal failure.
    Cooper RA; Mirakhur RK; Wierda JM; Maddineni VR
    Eur J Anaesthesiol Suppl; 1995 Sep; 11():43-4. PubMed ID: 8557005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacokinetics of rocuronium bromide in hepatic cirrhosis.
    Hunter JM
    Eur J Anaesthesiol Suppl; 1995 Sep; 11():39-41. PubMed ID: 8557004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rocuronium bromide: time-course of action in underweight, normal weight, overweight and obese patients.
    Pühringer FK; Khuenl-Brady KS; Mitterschiffthaler G
    Eur J Anaesthesiol Suppl; 1995 Sep; 11():107-10. PubMed ID: 8556996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rocuronium 0.3 mg x kg-1 (ED95) induces a normal peak effect but an altered time course of neuromuscular block in patients with Duchenne's muscular dystrophy.
    Muenster T; Schmidt J; Wick S; Forst J; Schmitt HJ
    Paediatr Anaesth; 2006 Aug; 16(8):840-5. PubMed ID: 16884467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuromuscular recovery following rocuronium bromide single dose in infants.
    Rapp HJ; Altenmueller CA; Waschke C
    Paediatr Anaesth; 2004 Apr; 14(4):329-35. PubMed ID: 15078379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rocuronium bromide in the ICU: dose finding and pharmacokinetics.
    Khuenl-Brady KS; Sparr H; Pühringer F; Agoston S
    Eur J Anaesthesiol Suppl; 1995 Sep; 11():79-80. PubMed ID: 8557012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamics of rocuronium 0.3 mg kg(-1) in adult patients with and without renal failure.
    Robertson EN; Driessen JJ; Vogt M; De Boer H; Scheffer GJ
    Eur J Anaesthesiol; 2005 Dec; 22(12):929-32. PubMed ID: 16318664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and pharmacokinetic/dynamic relationship of rocuronium bromide in humans.
    Wierda JM; Proost JH; Schiere S; Hommes FD
    Eur J Anaesthesiol Suppl; 1994; 9():66-74. PubMed ID: 7925212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atracurium, cisatracurium, vecuronium and rocuronium in patients with renal failure.
    Della Rocca G; Pompei L; Coccia C; Costa MG; Cecchini V; Vilardi V; Pietropaoli P
    Minerva Anestesiol; 2003; 69(7-8):605-11, 612, 5. PubMed ID: 14564242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuromuscular pharmacodynamics of rocuronium in patients with major burns.
    Han T; Kim H; Bae J; Kim K; Martyn JA
    Anesth Analg; 2004 Aug; 99(2):386-92, table of contents. PubMed ID: 15271712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and duration of residual paralysis at the end of surgery after multiple administrations of cisatracurium and rocuronium.
    Maybauer DM; Geldner G; Blobner M; Pühringer F; Hofmockel R; Rex C; Wulf HF; Eberhart L; Arndt C; Eikermann M
    Anaesthesia; 2007 Jan; 62(1):12-7. PubMed ID: 17156221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recovery of neuromuscular block in morbidly obese patients following an infusion of rocuronium.
    Spoelders K; van Duffel L; Vandermeersch E; Adriaenssens G; Van de Velde M
    Acta Anaesthesiol Belg; 2001; 52(3):293-5. PubMed ID: 11732386
    [No Abstract]   [Full Text] [Related]  

  • 17. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study.
    de Boer HD; Driessen JJ; Marcus MA; Kerkkamp H; Heeringa M; Klimek M
    Anesthesiology; 2007 Aug; 107(2):239-44. PubMed ID: 17667567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of neuromuscular block of atracurium and rocuronium in adults.
    Hans P; Brichant JF; Franzen A; Faleres X; Lamy M
    Acta Anaesthesiol Belg; 1996; 47(2):53-8. PubMed ID: 8869671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Target controlled infusion of rocuronium: selection of a pharmacokinetic model.
    Vermeyen KM; Hoffmann VL; Saldien V; Adriaensen HF
    Acta Anaesthesiol Belg; 2002; 53(1):17-9. PubMed ID: 11975424
    [No Abstract]   [Full Text] [Related]  

  • 20. Multicenter trial of prolonged infusions of rocuronium bromide in critically ill patients: effects of multiple organ failure.
    Circeo LE; Reeves ST
    South Med J; 2001 Jan; 94(1):36-42. PubMed ID: 11213940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.